Sort
25,944 grants matching “neurodegeneration”
Chemical and Structural Approaches to Study Energy Homeostasis Pathways in Cancer and Metabolic disorders
$464,453Michael Block Lazarus · Icahn School Of Medicine At Mount Sinai · R35 · FY2023 · GM
Chemical and Structural Approaches to Study Energy Homeostasis Pathways in Cancer and Metabolic disorders
$464,453Michael Block Lazarus · Icahn School Of Medicine At Mount Sinai · R35 · FY2022 · GM
Astrocytes in Retrovirus-Induced Spongiform Motor Neuron Disease
$464,412William P Lynch · Northeast Ohio Medical University · R15 · FY2018 · NS
Lyme neuroborreliosis pathogenesis in the rhesus monkey
$464,366Mario Tomas Philipp · Tulane University Of Louisiana · R01 · FY2006 · NS
Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases
$464,195Rebecca Eh Whiting · University Of Missouri-Columbia · R01 · FY2021 · EY
Cell Specific Proteomics highlights Molecular signatures of Manganese neurotoxicity in Dopaminergic neurons in vivo
$464,133Souvarish Sarkar · University Of Rochester · R21 · FY2025 · ES
Project 1: Tau metabolism: molecular chaperones, targeting and proteolysis
$464,093Aimee Kao · University Of California, San Francisco · U54 · FY2022 · NS
Poor Sleep Altered Circadian Rhythms and Alzheimers Disease
$463,994Adam Peter Spira · Johns Hopkins University · R01 · FY2016 · AG
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit
$463,917Karsten Gronert · University Of California Berkeley · R01 · FY2021 · EY
Metabolic basis of the NADPH-independent disulfide reductase system in mouse liver
$463,916Edward E Schmidt · Montana State University - Bozeman · R56 · FY2019 · DK
Developing Novel Neuroprotective Strategies for EAE/Optic Neuritis
$463,710Yang Hu · Stanford University · R01 · FY2018 · EY
Formation and Function of Glycolytic Bodies in Hypoxia
$463,628John Kim · Johns Hopkins University · R01 · FY2021 · GM
Formation and Function of Glycolytic Bodies in Hypoxia
$463,628John Kim · Johns Hopkins University · R01 · FY2020 · GM
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
$463,515William C Mobley · University Of California, San Diego · R01 · FY2019 · AG
E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma
$463,441Pawan Sharma · Thomas Jefferson University · R01 · FY2024 · HL
Manipulation of Mitochondrial Genomes in Aging and Neurodegeneration
$463,346James Pepper Bennett · Gencia Corporation · R42 · FY2006 · AG
Environmental Metals, Excitotoxicity and ALS
$463,248William D Atchison · Michigan State University · R01 · FY2015 · ES
Optic-nerve-head (ONH) Chips for Glaucomatous Neurodegeneration
$463,167Yong Yang · University Of North Texas · R15 · FY2022 · EY
Caspases, Calpains and Neuronal Cell death
$463,125Burnham Institute For Medical Research · R01 · FY2003 · NS
The PPAR-delta pathway in neural function and Huntington's disease neuropathology
$463,113Albert R La Spada · Duke University · R01 · FY2019 · NS
Cell Signaling and Neurodegeneration
$463,111Harry T. Orr · University Of Minnesota · R01 · FY2013 · NS
EXCITATION AND EXCITOTOXICITY IN TYPE I COCHLEAR AFFERENTS: SYNAPTIC STRUCTURE AND FUNCTION
$462,961Mark Allen Rutherford · Washington University · R01 · FY2016 · DC
Meningeal ectopic lymphoid tissues (mELTs): Composition, organization and expression revealed by imaging and in situ transcriptomics
$462,960Joel S Pachter · University Of Connecticut Sch Of Med/Dnt · R01 · FY2024 · NS
Development of Mouse Models of PD
$462,948Brigham And Women'S Hospital · P50 · FY2005 · NS
GHSR1a and hippocampal pathology in Alzheimer's Disease
$462,920Heng Du · University Of Texas Dallas · R01 · FY2018 · AG